5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

Detalles Bibliográficos
Autores principales: Callaghan, M., Ataga, K.I., De Franceschi, L., Minniti, C., Balachandran, N., Imbs, D.-.C., Perretti, T., Ramos, J., Sostelly, A., Bartolucci, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112576/
http://dx.doi.org/10.1097/01.HS9.0000928320.14894.77
_version_ 1785027650899673088
author Callaghan, M.
Ataga, K.I.
De Franceschi, L.
Minniti, C.
Balachandran, N.
Imbs, D.-.C.
Perretti, T.
Ramos, J.
Sostelly, A.
Bartolucci, P.
author_facet Callaghan, M.
Ataga, K.I.
De Franceschi, L.
Minniti, C.
Balachandran, N.
Imbs, D.-.C.
Perretti, T.
Ramos, J.
Sostelly, A.
Bartolucci, P.
author_sort Callaghan, M.
collection PubMed
description
format Online
Article
Text
id pubmed-10112576
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101125762023-04-19 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) Callaghan, M. Ataga, K.I. De Franceschi, L. Minniti, C. Balachandran, N. Imbs, D.-.C. Perretti, T. Ramos, J. Sostelly, A. Bartolucci, P. Hemasphere Poster Presentations Lippincott Williams & Wilkins 2023-04-10 /pmc/articles/PMC10112576/ http://dx.doi.org/10.1097/01.HS9.0000928320.14894.77 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster Presentations
Callaghan, M.
Ataga, K.I.
De Franceschi, L.
Minniti, C.
Balachandran, N.
Imbs, D.-.C.
Perretti, T.
Ramos, J.
Sostelly, A.
Bartolucci, P.
5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_fullStr 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full_unstemmed 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_short 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_sort 5612539 trial in progress: the randomized, double-blind, placebo-controlled phase 2a crosswalk-c trial evaluating the efficacy of crovalimab as adjunct treatment in the prevention of vaso-occlusive episodes (voes) in patients (pts) with sickle cell disease (scd)
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112576/
http://dx.doi.org/10.1097/01.HS9.0000928320.14894.77
work_keys_str_mv AT callaghanm 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT atagaki 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT defranceschil 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT minnitic 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT balachandrann 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT imbsdc 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT perrettit 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT ramosj 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT sostellya 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT bartoluccip 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd

Ejemplares similares